The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas

Despite the recent implementation of immunotherapy as a single treatment or in combination with chemotherapy for first-line treatment of advanced non-small cell lung cancer (NSCLC), many patients do not benefit from this regimen due to primary treatment resistance or toxicity. Consequently, there is...

Descripción completa

Detalles Bibliográficos
Autores principales: Mograbi, Baharia, Heeke, Simon, Hofman, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912095/
https://www.ncbi.nlm.nih.gov/pubmed/33572782
http://dx.doi.org/10.3390/diagnostics11020196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912095/
https://www.ncbi.nlm.nih.gov/pubmed/33572782
http://dx.doi.org/10.3390/diagnostics11020196

Ejemplares similares